Shanghai Runda Medical Technology Co Ltd
SSE:603108

Watchlist Manager
Shanghai Runda Medical Technology Co Ltd Logo
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Watchlist
Price: 13.55 CNY 2.34%
Market Cap: ¥8.2B

Shanghai Runda Medical Technology Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shanghai Runda Medical Technology Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Net Income (Common)
-¥157.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Net Income (Common)
¥19.2B
CAGR 3-Years
30%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Net Income (Common)
¥1.7B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Net Income (Common)
¥4.9B
CAGR 3-Years
4%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Net Income (Common)
¥887.9m
CAGR 3-Years
-24%
CAGR 5-Years
-13%
CAGR 10-Years
19%
W
WuXi XDC Cayman Inc
HKEX:2268
Net Income (Common)
¥1.5B
CAGR 3-Years
112%
CAGR 5-Years
124%
CAGR 10-Years
N/A
No Stocks Found

Shanghai Runda Medical Technology Co Ltd
Glance View

Shanghai Runda Medical Technology Co Ltd, nestled in the bustling heart of China's economic capital, stands as a quintessential example of a company thriving at the crossroads of innovation and healthcare. Established as a key player in medical diagnostics, Runda Medical focuses on the distribution and provision of high-quality medical devices and diagnostic solutions. Their business model revolves around integrating advanced technology with healthcare needs, enabling medical institutions to enhance their diagnostics capabilities through cutting-edge equipment and robust system support. The company holds a substantial portfolio of both proprietary and partnered products, allowing healthcare providers faster and more precise diagnostic insights. This is bolstered by a dependable supply chain and comprehensive after-sales service, ensuring that medical institutions can rely on consistent performance from their systems. Runda Medical's financial engine is powered predominantly by its distribution networks and strategic partnerships with leading medical technology firms worldwide. By leveraging these alliances, the company can offer a wide range of products that serve various segments of the medical industry, including hospitals, clinics, and laboratories. Revenue flows are primarily generated through the sale of medical devices such as automated analyzers, imaging systems, and diagnostic reagents — all designed to meet the growing demands for efficiency and accuracy in healthcare diagnosis. Moreover, their value proposition is further enhanced by the company's investments in customer education and training, ensuring that the end-users of their systems are not just purchasers but long-term partners in progress, thereby solidifying Runda Medical's reputation as a steadfast ally in China's healthcare landscape.

Intrinsic Value
23.33 CNY
Undervaluation 42%
Intrinsic Value
Price ¥13.55

See Also

What is Shanghai Runda Medical Technology Co Ltd's Net Income (Common)?
Net Income (Common)
-157.8m CNY

Based on the financial report for Sep 30, 2025, Shanghai Runda Medical Technology Co Ltd's Net Income (Common) amounts to -157.8m CNY.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett